OX40 is a potent immune-stimulating target in late-stage cancer patients

Brendan D. Curti, Magdalena Kovacsovics-Bankowski, Nicholas Morris, Edwin Walker, Lana Chisholm, Kevin Floyd, Joshua Walker, Iliana Gonzalez, Tanisha Meeuwsen, Bernard A. Fox, Tarsem Moudgil, William Miller, Daniel Haley, Todd Coffey, Brenda Fisher, Laurie Delanty-Miller, Nicole Rymarchyk, Tracy Kelly, Todd Crocenzi, Eric BernsteinRachel Sanborn, Walter J. Urba, Andrew D. Weinberg

    Research output: Contribution to journal › Article › peer-review

    395 Scopus citations

    Fingerprint

    Dive into the research topics of 'OX40 is a potent immune-stimulating target in late-stage cancer patients'. Together they form a unique fingerprint.

    Medicine & Life Sciences